Table of contents

  • Preliminary material
    • Contents
    • Acknowledgments
    • Abbreviations
    • Symbols
  • Body section
    • 1 Introduction to the NOPSAD collection
      • What is the NOPSAD collection and why was it developed?
      • What is the NOPSAD collection used for?
      • Purpose and structure of the NOPSAD data guide
    • 2 Scope of the NOPSAD data collection
    • 3 NOPSAD counting rules
      • Number of prescribers
      • Prescriber type
      • Number of clients by prescriber type
      • Clients per prescriber
    • 4 Administrative features in each jurisdiction
    • 5 Process for transmission, collation and reporting
    • 6 Data item definitions
      • Client age in years
      • Client Indigenous status
      • Client sex
      • Pharmacotherapy dosing point site locality
      • Pharmacotherapy dosing point site
      • Pharmacotherapy dosing point site identifier
      • Pharmacotherapy drug
      • Pharmacotherapy prescriber
      • Pharmacotherapy prescriber identifier
      • Pharmacotherapy prescriber type
      • Pharmacotherapy client
      • Pharmacotherapy client identifier
    • 7 Data required for the NOPSAD collection—unit record level
      • Pharmacotherapy client identifier
      • State
      • Pharmacotherapy drug
      • Pharmacotherapy prescriber type
      • Pharmacotherapy dosing point site type
      • Sex of client 
      • Client age in years 
      • Client Indigenous status
      • Pharmacotherapy prescriber identifier
      • Pharmacotherapy dosing point site identifier
      • Pharmacotherapy dosing point site locality
    • 8 Data required for the NOPSAD collection—aggregate level
      • Number of clients receiving pharmacotherapy drugs
      • Number of clients by pharmacotherapy drug type and prescriber type
      • Number of clients by pharmacotherapy drug type and dosing point site
      • Number of pharmacotherapy prescribers  
      • Number of pharmacotherapy dosing sites 
      • Sex of clients
      • Client age in years
      • Indigenous status of clients
      • Number of prescribers by prescriber type
      • Dosing point site locality
    • 9 NOPSAD privacy and data principles
    • 10 Data release guidelines for the NOPSAD collection
  • End matter
    • Appendixes
      • Appendix A: 2012 transmission specifications
    • References